A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Westpac looks seaward to boost NZ's economy
Primary Sector

Westpac looks seaward to boost NZ's economy

A senior scientist says less red tape could transform the aquaculture industry.

Greg Hurrell 20 Feb 2025
Fonterra still looking at trade sale and IPO options
Primary Sector

Fonterra still looking at trade sale and IPO options

Fonterra says it is thoroughly testing both options. 

Rebecca Howard 19 Feb 2025
What's behind Synlait's rapid share price rise?
Primary Sector

What's behind Synlait's rapid share price rise?

The shares started the year at 40c – and have now passed $1. 

The influential Chinese reviewer testing a2 Milk
Primary Sector

The influential Chinese reviewer testing a2 Milk

'Incredibly' influential consumer advocate visited A2 factories and farms in NZ.